Akhilesh Nand

Global Head – GRC (Governance, Risk, Compliance) & Company Secretary

Akhilesh is responsible for leading the global governance functions, including corporate secretarial, internal audit, risk management, corporate & commercial compliance, and internal investigations.

Akhilesh is an accomplished legal expert with 25 years of multi-industry experience in managing legal affairs, large M&A transactions, internal audits, risk management, strategic commercial transactions, antitrust issues, intellectual property, and integration and transformation planning, apart from driving the institutionalization of ethics and compliance programs. He has been instrumental in two of the largest M&A deals in the Indian pharma market: the first was the successful merger of Ranbaxy Laboratories with Sun Pharmaceuticals, and the second was Biocon’s acquisition of the global biosimilars business of Viatris.

Additionally, Akhilesh has extensive global experience in negotiating complex deals and resolving legal disputes. He demonstrates expertise and ability in aligning legal strategies with business objectives.

Over the past 9+ years at Biocon Biologics, Akhilesh has played an invaluable role in building a strong Legal, Risk, Compliance, Audit and Secretarial function from the bottoms-up in-line with evolving business needs. He has successfully led several large business transactions such as the recent acquisition of Viatris’ global biologics business, Private Equity fundraises, the Sandoz Collaboration and Vaccines deal with Serum Institute of India to list a few. He has been a champion of corporate governance and has put in place a robust infrastructure for Risk, Audit and Compliance management working closely with the CEO and the Board of Directors.

Akhilesh is a law graduate from the Delhi University and is a member of the Institute of Company Secretaries of India (ICSI).